Publications by authors named "Bebear C"

Carbapenem-resistant Pseudomonas aeruginosa is a global public health concern. IMP-13 is a carbapenemase that was described for the first time in 2001 but is often underestimated due to poor hydrolysis of carbapenems and a lack of molecular detection. The aim of this study was to characterize the genetic support of bla in P.

View Article and Find Full Text PDF

Purpose: Non-optimal vaginal microbiota lacking lactobacilli and comprising a wide array of anaerobic bacteria, typified by community state type (CST) IV, have been associated with adverse gynecological and pregnancy outcomes. Here, we investigate the stability of the vaginal microbiota sampled every 6 months over 18 months and how samples distantly collected combined with exposures could provide insight on future microbiota compositional changes.

Methods: Vaginal microbiota dynamics were analyzed in 241 female students aged 18-24 years and negative for Chlamydia trachomatis and Neisseria gonorrhoeae.

View Article and Find Full Text PDF
Article Synopsis
  • Since 2022, Europe has identified 4 cases of extensively drug-resistant Neisseria gonorrhoeae, particularly sequence type 16406, which is resistant to ceftriaxone and has high resistance to azithromycin.
  • In 2023, two new related cases were reported in France that share genetic links with the previous European cases and strains from Cambodia.
  • This highlights growing concerns about the spread of drug-resistant gonorrhea in Europe and its potential global implications.
View Article and Find Full Text PDF

Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in children and young adults. It is responsible of a broad array of extrapulmonary manifestations, the most severe affecting the central nervous system. We report a challenging diagnosis of macrolide-resistant M.

View Article and Find Full Text PDF

Unlabelled: Antimicrobial susceptibility testing (AST) of human mycoplasmas using microdilution is time-consuming. In this study, we compared the performance of MICRONAUT-S plates (Biocentric-Bruker) designed for AST of , , and with the results using the Clinical & Laboratory Standards Institute (CLSI) reference method. Then, we investigated the prevalence and mechanisms of resistance to tetracyclines, fluoroquinolones, and macrolides in France in 2020 and 2021.

View Article and Find Full Text PDF

Background: Increased rates of sexually transmitted infections (STIs) are reported among men who have sex with men (MSM) and new interventions are needed. We aimed to assess whether post-exposure prophylaxis (PEP) with doxycycline could reduce the incidence of chlamydia or syphilis (or both) and whether the meningococcal group B vaccine (4CMenB) could reduce the incidence of gonorrhoea in this population.

Methods: ANRS 174 DOXYVAC is a multicentre, open-label, randomised trial with a 2 × 2 factorial design conducted at ten hospital sites in Paris, France.

View Article and Find Full Text PDF
Article Synopsis
  • In France, a nationwide survey from 2020 to 2022 reinstated universal LGV testing after switching to selective testing in 2016, focusing on samples from men and women with anorectal positivity.
  • The results showed stable LGV positivity rates among men who have sex with men (MSM) but a notable increase in asymptomatic cases, rising from 36.1% in 2020 to 52.4% in 2022.
  • The findings emphasize the importance of universal LGV testing and ongoing surveillance due to the increase in asymptomatic cases and changes in genotypes observed in the study.
View Article and Find Full Text PDF

The pathogenicity of is poorly understood, mainly due to the absence of efficient genetic tools. A polyethylene glycol-mediated transformation protocol was recently developed for the reference strain M132 using the pMT85-Tet plasmid. The transformation efficiency remained low, hampering generation of a large mutant library.

View Article and Find Full Text PDF

We report two extensively drug-resistant (XDR) (NG) isolates combining high-level resistance to azithromycin and resistance to ceftriaxone, obtained in France from two heterosexual patients, one of whom returned from Cambodia. Whole genome sequencing identified MLST ST16406, the mosaic -60.001 which caused ceftriaxone resistance in the internationally spreading FC428 clone, and the A2059G mutation in the 23S rRNA gene.

View Article and Find Full Text PDF

Objective: Many experimental studies have been conducted to evaluate vascular and endovascular graft infections (VGEIs) and infectability in order to elaborate strategies to prevent or to treat their occurrence. A systematic literature search was conducted to collect and summarise key features of infection and infectability assessment techniques in VGEI experimental models.

Methods: The literature search was conducted using the Medline and Cochrane databases, with no limit on the date of publication, until 10 August 2021.

View Article and Find Full Text PDF

prevalence was assessed in urogenital samples from men screened for and . Prevalence was 3.5% among men who have sex with men and 5.

View Article and Find Full Text PDF

We report a ceftriaxone-resistant, multidrug-resistant urogenital gonorrhoea case in a heterosexual woman in France, June 2022. The woman was successfully treated with azithromycin 2 g. She had unprotected sex with her regular partner, who developed urethritis following travel to Vietnam and Switzerland.

View Article and Find Full Text PDF

It is of international priority to develop a vaccine against sexually transmitted infections to combat the continued global spread of the infection. The optimal immunization strategy still remains to be fully elucidated. The aim of this study was to evaluate immunization strategies in a nonhuman primate (NHP) model.

View Article and Find Full Text PDF
Article Synopsis
  • A multicenter study in France from 2018 to 2020 examined the prevalence of macrolide and fluoroquinolone resistance mutations in patients.
  • In metropolitan France, macrolide resistance was found in 34.7% to 42.9% of cases, significantly higher in men compared to women, whereas in overseas France, it was only 6.1% to 14.7%.
  • The study concluded that metropolitan France has a notably high prevalence of these mutations compared to overseas regions, with a marked gender disparity in macrolide resistance.
View Article and Find Full Text PDF

The high prevalence of macrolide resistance in Mycoplasma genitalium results in an increased reliance on moxifloxacin, the second-line treatment; however, moxifloxacin resistance has also emerged. Because assays that can detect fluoroquinolone resistance-associated mutations will be useful for the management of macrolide-resistant M. genitalium infections, we evaluated the performance of three commercial assays (the Allplex MG & MoxiR Assay [Seegene], LightMix Modular parC kit [TIBMOLBIOL], and MGMO qPCR [NYtor) in comparison with gene Sanger sequencing used as the reference.

View Article and Find Full Text PDF

BackgroundDiagnoses of bacterial sexually transmitted infections (STIs) have increased in France since the 2000s. The main strategy to control STI transmission is recommending/facilitating access to condom use, testing, and antibiotic treatments.AimThis study analyses the evolution of STI testing in the private sector in France from 2006 to 2020.

View Article and Find Full Text PDF

Mycoplasma genitalium causes sexually transmitted infecti.ons in men and women. Treatment failures to macrolides and fluoroquinolones have been reported worldwide.

View Article and Find Full Text PDF
Article Synopsis
  • - A 45-year-old woman being treated with rituximab for B cell non-Hodgkin follicular lymphoma developed recurrent fever, stomach pain, and frequent urination.
  • - Doctors conducted metagenomic sequencing on a sample near her kidney and discovered she had two infections: Mycoplasma hominis and Ureaplasma urealyticum.
  • - After receiving the right antibiotics, the patient improved but experienced some lasting effects from the infections.
View Article and Find Full Text PDF

Background respiratory infections are transmitted by aerosol and droplets in close contact.AimWe investigated global incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March 2020.MethodsWe surveyed detections from laboratories and surveillance systems (national or regional) across the world from 1 April 2020 to 31 March 2021 and compared them with cases from corresponding months between 2017 and 2020.

View Article and Find Full Text PDF

Background: Anorectal infections with Chlamydia trachomatis are commonly found in women. Although the efficacy of doxycycline and azithromycin is comparable in the treatment of urogenital infection, their efficacies toward anorectal infection remain unclear. We therefore aimed to compare a single dose of azithromycin with a 7-day course of doxycycline for the treatment of anorectal C trachomatis infection in women with concurrent vaginal infection.

View Article and Find Full Text PDF